These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9291994)

  • 1. Inhibition of human leukocyte elastase activity by chondroitin sulfates.
    Volpi N
    Chem Biol Interact; 1997 Aug; 105(3):157-67. PubMed ID: 9291994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chondroitin sulfates with different structures on leukemia cells: U-937 cell proliferation and differentiation.
    Volpi N; Bolognani L; Conte A; Petrini M
    Leuk Res; 1993 Sep; 17(9):789-98. PubMed ID: 7690435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human leukocyte elastase by chemically and naturally oversulfated galactosaminoglycans.
    Bartolucci C; Cellai L; Iannelli MA; Lamba D; Liverani L; Mascellani G; Perola E
    Carbohydr Res; 1995 Oct; 276(2):401-8. PubMed ID: 8542607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human leukocyte elastase activity by heparins: influence of charge density.
    Volpi N
    Biochim Biophys Acta; 1996 Aug; 1290(3):299-307. PubMed ID: 8765134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of chondroitin ABC lyase and hyaluronidase on free-radical degraded chondroitin sulfate.
    Volpi N; Sandri I; Venturelli T
    Carbohydr Res; 1995 Dec; 279():193-200. PubMed ID: 8593623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of chondroitin sulfate and dermatan sulfate with chondroitin lyases.
    Hernáiz MJ; Linhardt RJ
    Methods Mol Biol; 2001; 171():363-71. PubMed ID: 11450250
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma.
    Volpi N; Cusmano M; Venturelli T
    Biochim Biophys Acta; 1995 Jan; 1243(1):49-58. PubMed ID: 7827107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical characteristics and antithrombotic effect of chondroitin sulfates from sturgeon skull and sturgeon backbone.
    Gui M; Song J; Zhang L; Wang S; Wu R; Ma C; Li P
    Carbohydr Polym; 2015 Jun; 123():454-60. PubMed ID: 25843879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties.
    Krichen F; Bougatef H; Sayari N; Capitani F; Ben Amor I; Koubaa I; Maccari F; Mantovani V; Galeotti F; Volpi N; Bougatef A
    Carbohydr Polym; 2018 Oct; 197():451-459. PubMed ID: 30007634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification, structural characterization and anticoagulant properties of fucosylated chondroitin sulfate isolated from Holothuria mexicana.
    Mou J; Wang C; Li W; Yang J
    Int J Biol Macromol; 2017 May; 98():208-215. PubMed ID: 28153461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
    Fonseca RJ; Santos GR; Mourão PA
    Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between human leukocyte elastase and chondroitin sulfate.
    Baici A; Bradamante P
    Chem Biol Interact; 1984 Sep; 51(1):1-11. PubMed ID: 6430574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of unsaturated hexasaccharides isolated from shark cartilage chondroitin sulfate D that are substrates for the exolytic action of chondroitin ABC lyase.
    Sugahara K; Nadanaka S; Takeda K; Kojima T
    Eur J Biochem; 1996 Aug; 239(3):871-80. PubMed ID: 8774738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of inorganic sulfate ion under mild alkaline conditions from sulfated, unsaturated disaccharides obtained from chondroitin sulfates by chondroitinase digestion.
    Inoue H; Nakayama R; Otsu K; Habuchi H; Suzuki S; Nakanishi Y
    Carbohydr Res; 1986 Nov; 155():277-82. PubMed ID: 3098423
    [No Abstract]   [Full Text] [Related]  

  • 15. Separation, purification, structures and anticoagulant activities of fucosylated chondroitin sulfates from Holothuria scabra.
    Yang L; Wang Y; Yang S; Lv Z
    Int J Biol Macromol; 2018 Mar; 108():710-718. PubMed ID: 29174356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture.
    Volpi N
    Anal Biochem; 1994 May; 218(2):382-91. PubMed ID: 8074297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of chondroitin sulfate libraries containing disulfated disaccharide units and inhibition of thrombin by these chondroitin sulfates.
    Numakura M; Kusakabe N; Ishige K; Ohtake-Niimi S; Habuchi H; Habuchi O
    Glycoconj J; 2010 Jul; 27(5):479-89. PubMed ID: 20467806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect.
    Bougatef H; Krichen F; Capitani F; Amor IB; Maccari F; Mantovani V; Galeotti F; Volpi N; Bougatef A; Sila A
    Carbohydr Polym; 2018 Sep; 196():272-278. PubMed ID: 29891297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a low-sulfated chondroitin sulfate from the body of Viviparus ater (mollusca gastropoda). Modification of its structure by lead pollution.
    Volpi N; Mucci A
    Glycoconj J; 1998 Nov; 15(11):1071-8. PubMed ID: 10386891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation.
    Maruyama T; Toida T; Imanari T; Yu G; Linhardt RJ
    Carbohydr Res; 1998 Jan; 306(1-2):35-43. PubMed ID: 9691438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.